AD Not Linked to Early CV Risk Markers - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

  • By

  • Kathryn Wighton

  • May 27, 2026

  • 5 min

Share

Clinical Scorecard: AD Not Linked to Early CV Risk Markers

At a Glance

CategoryDetail
Condition
Key MechanismsNo consistent association with specific cardiometabolic risk markers.
Target Population
Care Setting

Key Highlights

  • Clarify the nature of associations with LDL-C and HDL-C.

Guideline-Based Recommendations

Diagnosis

    Management

    • Include specific recommendations from the source.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Children and adolescents with atopic dermatitis.

        Focus on symptom management rather than cardiovascular risk.

        Clinical Best Practices

        • Ensure practices are directly supported by the source material.

        Related Resources & Content

        Original Source(s)

        AD Not Linked to Early CV Risk Markers

        • by Kathryn Wighton

        • May 27, 2026

        Related Content

        TOFA may drive weight loss without reducing food intake

        The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

        Tricuspid regurgitation thresholds reassessed

        The proposed framework classified 30% of patients as high or extreme risk, compared with 12% classified as having severe or greater tricuspid regurgitation under established grading schemes.

        FDA monthly preview: Key September decisions to watch

        Several FDA decisions across multiple specialties are expected this month.